Skip to main content

Premature Birth clinical trials at UCLA

3 in progress, 2 open to eligible people

Showing trials for
  • Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

    open to all eligible people

    A comprehensive analysis of the impact of exogenous enteral DHA and ARA supplementation on lipid metabolism including the production of downstream derived mediators and how this impacts important biological pathways such as metabolism, inflammation, and organogenic factors.

    Los Angeles 5368361, California 5332921 and other locations

  • Follow-up Visit of High Risk Infants

    open to eligible people ages 18 months to 26 months

    The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort in which surviving extremely low birth-weight infants born in participating network centers receive neurodevelopmental, neurosensory and functional assessments at 22-26 months corrected age (Infants born prior to July 1, 2012 were seen at 18-22 months corrected age). Data regarding pregnancy and neonatal outcome are collected prospectively. The goal is to identify potential maternal and neonatal risk factors that may affect infant neurodevelopment.

    Los Angeles 5368361, California 5332921 and other locations

  • IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study

    Sorry, in progress, not accepting new patients

    IBP-9414 will be evaluated in preterm infants with a birth weight of 500-1500g, compared to placebo with regards to efficacy and safety in the prevention of necrotizing enterocolitis.

    Los Angeles 5368361, California 5332921 and other locations

Our lead scientists for Premature Birth research studies include .

Last updated: